Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q2- Text added to 2021 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
accredited, agonism, Beckwith, bone, broad, calcium, chairman, collaboration, confined, constellation, deep, exclusive, exhibit, formation, Frazier, gene, Healthcare, HHM, Humoral, hyperactive, hypercalcemia, Kabuki, license, local, Malignancy, malignant, mutation, neurological, oncology, pancreatic, parathyroid, phosphate, PHPT, platform, pleiotropic, potent, President, PTH, PTHLH, PTHrP, reabsorption, remove, renal, resale, resorption, respond, role, Scott, serve, situation, skeletal, SPAC, stake, subset, suitable, surgery, Symptomatic, technology, therapy, travel, Turner, warrant, Wiedemann
Removed:
Administration, continuing, Food, half, lab
Valuein 2021 Q2 filing- Value in 2021 Q3 filing
Original filings
Filing view